Zhong P Q, Zhi F X, Li R, Xue J L, Shu G Y
Department of Head and Neck, Cancer Hospital of Shandong, Linyi, China.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998 Aug;86(2):139-44. doi: 10.1016/s1079-2104(98)90115-9.
From June 1987 to June 1995, 200 patients with various types of head and neck lymphangioma were treated by intratumorous injection of bleomycin-A5. All 200 cases were followed from 2 to 10 years; 95 cases were followed for more than 5 years. The effective rate was 97%, and the curative rate was 86.5%. No pulmofibrosis or other serious complications were found. The relationships between the curative effect and tumor type, size, and side effect of bleomycin are discussed.
1987年6月至1995年6月，对200例各种类型的头颈部淋巴管瘤患者采用博来霉素A5瘤内注射治疗。200例患者均随访2至10年；95例随访时间超过5年。有效率为97%，治愈率为86.5%。未发现肺纤维化或其他严重并发症。并讨论了疗效与肿瘤类型、大小以及博来霉素副作用之间的关系。
